| | Class 2 Device Recall Multiple |  |
| Date Initiated by Firm | November 22, 2025 |
| Date Posted | February 04, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1257-2026 |
| Recall Event ID |
97801 |
| Product Classification |
Test, urine leukocyte - Product Code LJX
|
| Product | LotFancy Urinary Tract Infection Urine (UTI) Test Strips;
PALINOIA UTI-10 PARAMETER REAGENT STRIPS;
Vaunn Medical 8-in-1 Urinalysis Reagent Strip;
JNW Direct 4-in-1 UTl Urinalysis Test Strips;
Urinify STRENGTH;
Urinify ESSENTIAL,
Urinify Urinary Tract Infection (UTI) |
| Code Information |
Name/Lot(Expiration):
LotFancy Urinary Tract Infection Urine (UTI) Test Strips/2025062001(06/19/2027);
LotFancy URS-3N Test Strip/2025033101(03-30-2027), 2025080801(08-07-2027), 2025090844(09-07-2027);
PALINOIA UTI-10 PARAMETER REAGENT STRIPS/2025042110(04-20-2027), 2025021001(02-20-2027);
Vaunn Medical 8-in-1 Urinalysis Reagent Strip/2024032508(03/24/2026), 2024071602(07/15/2026), 2024102108(10/20/2026);
JNW Direct 4-in-1 UTl Urinalysis Test Strips/30D25WC(04/29/2027), 02D25WC(04/01/2027), 30E25WC(05/29/2027), 10H24WC(07/10/2026);
Urinify STRENGTH/202403103-6(01/03/2026), 202504103-6(01/01/2027), 202505103-6(06/01/2027), 202504103-3(01/01/2027), 202505103-3(06/01/2027);
Urinify ESSENTIAL/202403104-6(01/03/2026), 202504104-6(01/01/2027), 202505104-6(06/01/2027), 202504104-3(01/01/2027), 202505104-3(06/01/2027);
Urinify Urinary Tract Infection (UTI)/202501105-5(01/02/2027) |
Recalling Firm/ Manufacturer |
Changchun Wancheng Bio-Electron Co., Ltd. 2336, Tianwei Road Beihu Science and Technology Development Zone Changchun China
|
Manufacturer Reason for Recall | Test strips and other tests including for near-patient testing, that require a 510(k) were distributed before they could be legally marketed to U.S. customers; devices may cause false or inaccurate diagnostic result by lay person and lead to inappropriate medical intervention. |
FDA Determined Cause 2 | No Marketing Application |
| Action | Starting on 11/22/2025, recall notices were mailed or emailed to customers/distributors who were asked to do the following:
1) Destroy unused devices.
2) Inform customers that test results may be inaccurate, and it is recommended to re-test.
3) If affected devices were further distributed, please forward this notice and response form to these additional customers or email us a customer distribution list with names, emails, addresses, phone numbers so we can notify your customers of the recall.
4) Complete and return the Acknowledgement and Receipt Form via email to: sales04@ccwancheng.com
Questions can be emailed to the firm at: sales01@ccwancheng.com / sales04@ccwancheng.com |
| Quantity in Commerce | 91,366 |
| Distribution | US Nationwide distribution in the states of TX, GA, CA. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|